Featured Research

from universities, journals, and other organizations

Test developed to assess effect of more than 1,500 chemicals on estrogen

Date:
February 18, 2014
Source:
City of Hope
Summary:
A screening assay has been developed that can quickly assess up to 1,536 compounds’ effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen. Even everyday chemicals have the potential to increase, or potentially decrease, the risk of breast cancer, researchers say, and note that "approximately 70 percent of breast cancers are sensitive to estrogen, and exposure to estrogen-disrupting compounds -- especially during the critical periods of pregnancy, childhood and adolescence -- can have an irreversible impact on still-developing bodies."

A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.

Related Articles


The results verifying this novel screening method -- called AroER tri-screenTM -- are published ahead of print online in Toxicological Sciences. The test can screen for more than 1,500 compounds with each run, enabling scientists to rapidly assess and identify the estrogen-disrupting impact of common chemicals. Even everyday chemicals have the potential to increase, or potentially decrease, the risk of breast cancer, researchers say.

"Approximately 70 percent of breast cancers are sensitive to estrogen, and exposure to estrogen-disrupting compounds -- especially during the critical periods of pregnancy, childhood and adolescence -- can have an irreversible impact on still-developing bodies," said Shiuan Chen, Ph.D., professor and chair of City of Hope's Department of Cancer Biology and lead author of the study. "Thus, it makes sense to develop this test, which can assess many chemicals at once, to help us quickly identify which environmental compounds are disrupting estrogen functions."

The screening method uses a microplate, a special plate containing miniature test tubes known as wells. In the wells are specially cultured estrogen-sensitive breast cancer cells treated to detect either estrogen-promoting or estrogen-suppressing properties of chemicals. The researchers collaborated with the Tox-21 program (a national effort to develop methods to screen for hazardous chemicals) to amplify the number of wells in the microplate -- from the original 96 to 1,536 -- greatly increasing the number of assessments each test can process.

In addition to confirming AroER tri-screen's effectiveness, the researchers found that antifungal medications oxiconazol (Oxistat) and bifonazole (Canespor) exhibited aromatase-inhibiting properties, while the antidepressant paroxetine (Paxil) acted as an estrogen promoter.

"The paroxetine finding helps explain previous studies showing that it reduces tamoxifen therapy's effectiveness," Chen said. "And it has implications for patients with estrogen-sensitive breast cancer who are on other medications."

Meanwhile, the oxiconazol and bifonazole findings mean that these drugs may have potential in treating estrogen-sensitive breast cancers by inhibiting aromatase and thus levels of estrogen in the body.

Given these promising findings, Chen said that he hopes the AroER tri-screenTM assay will be be used to assess the estrogen-disrupting properties of more compounds, including medications, environmental pollutants and common household chemicals.


Story Source:

The above story is based on materials provided by City of Hope. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Chen, D. Zhou, L.-Y. Hsin, N. Kanaya, C. Wong, R. Yip, S. Sakamuru, M. Xia, Y.-C. Yuan, K. Witt, C. Teng. AroER Tri-Screen  is a Biologically Relevant Assay for Endocrine Disrupting Chemicals Modulating the Activity of Aromatase and/or the Estrogen Receptor. Toxicological Sciences, 2014; DOI: 10.1093/toxsci/kfu023

Cite This Page:

City of Hope. "Test developed to assess effect of more than 1,500 chemicals on estrogen." ScienceDaily. ScienceDaily, 18 February 2014. <www.sciencedaily.com/releases/2014/02/140218142358.htm>.
City of Hope. (2014, February 18). Test developed to assess effect of more than 1,500 chemicals on estrogen. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2014/02/140218142358.htm
City of Hope. "Test developed to assess effect of more than 1,500 chemicals on estrogen." ScienceDaily. www.sciencedaily.com/releases/2014/02/140218142358.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins